Roche Engages U.S. Government on Drug Pricing, Boosts Domestic Production Amid Tariff Concerns
Key Takeaways Roche (RHHBY) is actively engaged in discussions with the U.S. government regarding drug pricing, exploring models like direct-to-patient […]
